Screener / SEC EDGAR /CIK 0001076930 /10-K filed Feb 23, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Miscellaneous Electrical Machinery, Equipment & Supplies

Novanta Inc NOVT

Compare with peers Embed
FY2025 at a glance

Sales up 3.3%, free cash flow down to $48.4M

XBRL, from each 10-K
RevenueStatements
$980.6M from $949.2M in FY2024
FY2016FY2025
Net incomeStatements
$53.8M from $64.1M in FY2024
FY2016FY2025
Free cash flowStatements
$48.4M from $141.3M in FY2024
FY2016FY2025
EPS (diluted)Statements
$1.47 from $1.77 in FY2024
FY2016FY2025
Operating marginStatements
9.6% from 11.6% in FY2024
FY2016FY2025
Total debtStatements
$250.8M from $416.6M in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (45)
EPS (ttm)
1.32
Sales (ttm)
1.1B
Net income (ttm)
53.1M
Sales growth
+3.3%
EPS growth
-16.9%
Sales Q/Q
+23.1%
Free cash flow
140.4M
Gross margin
44.5%
Oper. margin
7.8%
Net margin
4.9%
FCF margin
12.9%
ROE
3.3%
ROA
1.7%
R&D / sales
9.7%
Dividend
-
Debt/Eq
0.51
Curr. ratio
1.18
Cash
149.2M
Op. cash flow (ttm)
164.7M
EBITDA
155.9M
EBITDA margin
15.9%
Net debt
680.6M
Quick ratio
0.82
Interest cover
4.17
ROIC
3.0%
FCF after stock pay
18.9M
Debt / FCF (years)
17.13
Goodwill / assets
35.8%
Oper. margin low 5y
9.1%
Tax rate
22.7%
Stock pay / sales
3.0%
Shares out.
37.8M
Shares Y/Y
+1.6%
Book / share
42.95
Cash / share
3.95
Sales / share
28.74
Asset turnover
0.34
Inventory turns
2.90
Days sales out.
69
Sales 3Y CAGR
+4.4%
Sales 5Y CAGR
+10.7%
EPS 3Y CAGR
-10.6%
EPS 5Y CAGR
+3.3%
Employees
3,000
Sales / employee
362K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 980.6M +11.0% a year Net income 53.8M +10.5% a year
FY2016 revenue 384.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001564590-19-004717 FY2016 net income 22.0M · NetIncomeLoss, 0001564590-19-004717 384.8M FY2016 FY2017 revenue 521.3M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001564590-20-006601 FY2017 net income 60.1M · NetIncomeLoss, 0001564590-20-006601 521.3M FY2017 FY2018 revenue 614.3M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001564590-21-009673 FY2018 net income 49.1M · NetIncomeLoss, 0001564590-21-009673 614.3M FY2018 FY2019 revenue 626.1M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001564590-22-007880 FY2019 net income 40.8M · NetIncomeLoss, 0001564590-22-007880 626.1M FY2019 FY2020 revenue 590.6M · RevenueFromContractWithCustomerExcludingAssessedTax, 0000950170-23-005365 FY2020 net income 44.5M · NetIncomeLoss, 0000950170-23-005365 590.6M FY2020 FY2021 revenue 706.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0000950170-24-021689 FY2021 net income 50.3M · NetIncomeLoss, 0000950170-24-021689 706.8M FY2021 FY2022 revenue 860.9M · RevenueFromContractWithCustomerExcludingAssessedTax, 0000950170-25-026131 FY2022 net income 74.1M · NetIncomeLoss, 0000950170-25-026131 860.9M FY2022 FY2023 revenue 881.7M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001193125-26-064230 FY2023 net income 72.9M · NetIncomeLoss, 0001193125-26-064230 881.7M FY2023 FY2024 revenue 949.2M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001193125-26-064230 FY2024 net income 64.1M · NetIncomeLoss, 0001193125-26-064230 949.2M FY2024 FY2025 revenue 980.6M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001193125-26-064230 FY2025 net income 53.8M · NetIncomeLoss, 0001193125-26-064230 980.6M FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

From the same starting line, FY2016 to FY2025

Revenue, net income and free cash flow, each set to 100 in FY2016. What happened, from the 10-Ks. Not a forecast.

FY2016 = 100
100 200 300 Revenue: $384.8M in FY2016, $980.6M in FY2025 REVENUE $980.6M · 2.5x Net income: $22.0M in FY2016, $53.8M in FY2025 NET INCOME $53.8M · 2.4x Free cash flow: $39.3M in FY2016, $48.4M in FY2025 FREE CASH FLOW $48.4M · 1.2x FY2016 = 100FY2021FY2025
Revenue 2.5x $384.8M to $980.6M
Net income 2.4x $22.0M to $53.8M
Free cash flow 1.2x $39.3M to $48.4M

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share +3.7% a year FY2015 $1.02 to FY2025 $1.47, 10 years
Book value per share +17.7% a year FY2015 $7.03 to FY2025 $35.81, 10 years
Free cash flow per share +5.1% a year FY2015 $0.80 to FY2025 $1.32, 10 years
200 400 100 EPS: $1.02 in FY2015, $1.47 in FY2025 EPS $1.47 · 1.4x Book value / share: $7.03 in FY2015, $35.81 in FY2025 BOOK VALUE / SHARE $35.81 · 5.1x FCF / share: $0.80 in FY2015, $1.32 in FY2025 FCF / SHARE $1.32 · 1.6x FY2015 = 100FY2020FY2025

Each line is set to 100 in FY2015, so a line at 200 has doubled. What was filed, not a forecast. A line is left out when it is not above zero in every year.

Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $1.47$35.81$1.32
Dec 31, 2024 $1.77$20.64$3.91
Dec 31, 2023 $2.02$18.69$2.78
Dec 31, 2022 $2.06$16.08$1.98
Dec 31, 2021 $1.41$14.57$2.09
Dec 31, 2020 $1.25$13.37$3.64
Dec 31, 2019 $1.15$11.74$1.48
Dec 31, 2018 $1.43$10.38$2.11
Dec 31, 2017 $1.13$8.83$1.54
Dec 31, 2016 $0.63$7.41$1.13
Dec 31, 2015 $1.02$7.03$0.80

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $782.6M
  • − All liabilities $492.8M
  • = Net current asset value $289.8M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $1.3B
  • − Goodwill $647.3M
  • − Other intangible assets $180.8M
  • = Tangible book value $486.2M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

NOVT against Technology peers

Among the 233 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+6.2%+24.1%
+3.3%188th of 231 · median +13.2%
Net margin
2.8%20.7%
4.9%158th of 229 · median 10.2%
Return on equity
3.1%24.0%
3.3%158th of 215 · median 12.7%
Free cash flow margin
8.4%27.8%
12.9%156th of 226 · median 20.0%
Debt / equity (less is better)
1.020.25
0.5168th of 141 · median 0.52
NOVT and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
NOVT Novanta Inc$1.1B +3.3%44.5%4.9%3.3%12.9%0.51
S SentinelOne, Inc.$1.1B +21.9%72.5%-31.0%-23.5%5.1%-
SMTC Semtech Corp$1.1B +15.5%51.6%-3.0%-5.8%15.9%0.86
APPF Appfolio Inc$1.1B +19.7%-15.6%29.2%25.9%-
ALRM Alarm.com Holdings, Inc.$1.1B +7.6%66.1%10.8%13.1%17.7%-
MIR Mirion Technologies, Inc.$1.1B +7.5%48.1%2.7%1.6%15.6%0.25
All 233 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by segment

From $706.8M of sales to $50.3M of profit FY2021

  • Medical Solutions $262.1M
  • Precision Medicine and Manufacturing $232.5M
  • Robotics and Automation $212.3M
Revenue to Gross profit: $300.3MRevenue to Cost of revenue: $406.5MGross profit to Operating profit: $64.1MGross profit to Operating expenses: $236.3MOperating profit to Net profit: $50.3MOperating profit to Tax & other: $13.7MOperating expenses to R&D: $72.5MOperating expenses to Sales, admin & other: $163.8M Revenue: $706.8M REVENUE $706.8M +20% Y/Y Gross profit: $300.3M · 42% margin GROSS PROFIT $300.3M 42% margin · +23% Y/Y Cost of revenue: $406.5M · 58% of revenue COST OF REVENUE $406.5M 58% of revenue Operating profit: $64.1M · 9% margin OPERATING PROFIT $64.1M 9% margin · +15% Y/Y Operating expenses: $236.3M · 33% of revenue OPERATING EXPENSES $236.3M 33% of revenue Net profit: $50.3M · 7% margin NET PROFIT $50.3M 7% margin · +13% Y/Y Tax & other: $13.7M · 2% of revenue TAX & OTHER $13.7M 2% of revenue R&D: $72.5M · 10% of revenue R&D $72.5M 10% of revenue Sales, admin & other: $163.8M · 23% of revenue SALES, ADMIN & OTHER $163.8M 23% of revenue

From $860.9M of sales to $74.1M of profit FY2022

Revenue to Gross profit: $378.5MRevenue to Cost of revenue: $482.4MGross profit to Operating profit: $103.1MGross profit to Operating expenses: $275.4MOperating profit to Net profit: $74.1MOperating profit to Tax & other: $29.0MOperating expenses to R&D: $85.8MOperating expenses to Sales, admin & other: $189.6M Revenue: $860.9M REVENUE $860.9M +22% Y/Y Gross profit: $378.5M · 44% margin GROSS PROFIT $378.5M 44% margin · +26% Y/Y Cost of revenue: $482.4M · 56% of revenue COST OF REVENUE $482.4M 56% of revenue Operating profit: $103.1M · 12% margin OPERATING PROFIT $103.1M 12% margin · +61% Y/Y Operating expenses: $275.4M · 32% of revenue OPERATING EXPENSES $275.4M 32% of revenue Net profit: $74.1M · 9% margin NET PROFIT $74.1M 9% margin · +47% Y/Y Tax & other: $29.0M · 3% of revenue TAX & OTHER $29.0M 3% of revenue R&D: $85.8M · 10% of revenue R&D $85.8M 10% of revenue Sales, admin & other: $189.6M · 22% of revenue SALES, ADMIN & OTHER $189.6M 22% of revenue

From $881.7M of sales to $72.9M of profit FY2023

Revenue to Gross profit: $399.9MRevenue to Cost of revenue: $481.8MGross profit to Operating profit: $110.5MGross profit to Operating expenses: $289.4MOperating profit to Net profit: $72.9MOperating profit to Tax & other: $37.6MOperating expenses to R&D: $91.7MOperating expenses to Sales, admin & other: $197.7M Revenue: $881.7M REVENUE $881.7M +2% Y/Y Gross profit: $399.9M · 45% margin GROSS PROFIT $399.9M 45% margin · +6% Y/Y Cost of revenue: $481.8M · 55% of revenue COST OF REVENUE $481.8M 55% of revenue Operating profit: $110.5M · 13% margin OPERATING PROFIT $110.5M 13% margin · +7% Y/Y Operating expenses: $289.4M · 33% of revenue OPERATING EXPENSES $289.4M 33% of revenue Net profit: $72.9M · 8% margin NET PROFIT $72.9M 8% margin · −2% Y/Y Tax & other: $37.6M · 4% of revenue TAX & OTHER $37.6M 4% of revenue R&D: $91.7M · 10% of revenue R&D $91.7M 10% of revenue Sales, admin & other: $197.7M · 22% of revenue SALES, ADMIN & OTHER $197.7M 22% of revenue

From $949.2M of sales to $64.1M of profit FY2024

  • Automation Enabling Technologies $490.6M
  • Medical Solutions $458.6M
Revenue to Gross profit: $421.5MRevenue to Cost of revenue: $527.7MGross profit to Operating profit: $110.6MGross profit to Operating expenses: $311.0MOperating profit to Net profit: $64.1MOperating profit to Tax & other: $46.5MOperating expenses to R&D: $95.5MOperating expenses to Sales, admin & other: $215.4M Revenue: $949.2M REVENUE $949.2M +8% Y/Y Gross profit: $421.5M · 44% margin GROSS PROFIT $421.5M 44% margin · +5% Y/Y Cost of revenue: $527.7M · 56% of revenue COST OF REVENUE $527.7M 56% of revenue Operating profit: $110.6M · 12% margin OPERATING PROFIT $110.6M 12% margin · +0% Y/Y Operating expenses: $311.0M · 33% of revenue OPERATING EXPENSES $311.0M 33% of revenue Net profit: $64.1M · 7% margin NET PROFIT $64.1M 7% margin · −12% Y/Y Tax & other: $46.5M · 5% of revenue TAX & OTHER $46.5M 5% of revenue R&D: $95.5M · 10% of revenue R&D $95.5M 10% of revenue Sales, admin & other: $215.4M · 23% of revenue SALES, ADMIN & OTHER $215.4M 23% of revenue

From $980.6M of sales to $53.8M of profit FY2025

  • Automation Enabling Technologies $500.8M
  • Medical Solutions $479.8M
Revenue to Gross profit: $435.3MRevenue to Cost of revenue: $545.3MGross profit to Operating profit: $94.0MGross profit to Operating expenses: $341.3MOperating profit to Net profit: $53.8MOperating profit to Tax & other: $40.2MOperating expenses to R&D: $95.5MOperating expenses to Sales, admin & other: $245.8M Revenue: $980.6M REVENUE $980.6M +3% Y/Y Gross profit: $435.3M · 44% margin GROSS PROFIT $435.3M 44% margin · +3% Y/Y Cost of revenue: $545.3M · 56% of revenue COST OF REVENUE $545.3M 56% of revenue Operating profit: $94.0M · 10% margin OPERATING PROFIT $94.0M 10% margin · −15% Y/Y Operating expenses: $341.3M · 35% of revenue OPERATING EXPENSES $341.3M 35% of revenue Net profit: $53.8M · 5% margin NET PROFIT $53.8M 5% margin · −16% Y/Y Tax & other: $40.2M · 4% of revenue TAX & OTHER $40.2M 4% of revenue R&D: $95.5M · 10% of revenue R&D $95.5M 10% of revenue Sales, admin & other: $245.8M · 25% of revenue SALES, ADMIN & OTHER $245.8M 25% of revenue

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity 4.1% FY2020: 9.3% net income ÷ equity
Net margin 5.5% FY2020: 7.5% profit per $ of sales: 53.8M ÷ 980.6M
Asset turnover 0.54× FY2020: 0.68× sales per $ of assets: 980.6M ÷ 1.8B
Leverage 1.37× FY2020: 1.81× assets per $ of equity: 1.8B ÷ 1.3B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    4.9% vs 10.2%
  • Gross margin up over 5 years
    41.4% → 44.4%
  • Return on equity below 15%
    3.3%
  • A profit in every one of 10 years
Net margin, FY2016 to FY2025: 5.7% to 5.5%

Balance sheet

  • Interest covered less than 5 times
    Operating income is 4.2× interest expense
  • Debt smaller than equity
    Debt / equity 0.51 on the latest balance sheet (peer median 0.52)
  • Current assets cover current liabilities
    Current ratio 1.18
  • Net debt over 3 years of free cash flow
    $680.6M net debt, 4.8 years
Debt / equity at each year end, FY2016 to FY2025: 0.30 to 0.19

Cash and shareholders

  • Free cash flow positive in every one of 10 years
    $48.4M last year
  • Share count up over 5 years
    +2.9%
  • Cash from operations above net income
    $64.1M vs $53.8M
Free cash flow, FY2016 to FY2025: 39.3M to 48.4M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$- of principal due

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities

Paid in advance $63.2M cash received before delivery, not yet recognized as revenue, Oct 2, 2026 · +670.7% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

NOVT's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue980.6M
FY2016: 384.8MFY2017: 521.3MFY2018: 614.3MFY2019: 626.1MFY2020: 590.6MFY2021: 706.8MFY2022: 860.9MFY2023: 881.7MFY2024: 949.2MFY2025: 980.6M FY2017FY2019FY2021FY2023FY2025
Net income53.8M
FY2016: 22.0MFY2017: 60.1MFY2018: 49.1MFY2019: 40.8MFY2020: 44.5MFY2021: 50.3MFY2022: 74.1MFY2023: 72.9MFY2024: 64.1MFY2025: 53.8M FY2017FY2019FY2021FY2023FY2025
Free cash flow48.4M
FY2016: 39.3MFY2017: 54.3MFY2018: 75.0MFY2019: 52.5MFY2020: 129.7MFY2021: 74.6MFY2022: 71.1MFY2023: 100.1MFY2024: 141.3MFY2025: 48.4M FY2017FY2019FY2021FY2023FY2025
Free cash flow after stock pay18.9M
FY2016: 35.0MFY2017: 48.8MFY2018: 67.3MFY2019: 43.2MFY2020: 106.6MFY2021: 49.0MFY2022: 48.0MFY2023: 74.5MFY2024: 118.0MFY2025: 18.9M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)1.47
FY2016: 0.63FY2017: 1.13FY2018: 1.43FY2019: 1.15FY2020: 1.25FY2021: 1.41FY2022: 2.06FY2023: 2.02FY2024: 1.77FY2025: 1.47 FY2017FY2019FY2021FY2023FY2025
Diluted shares36.7M
FY2016: 34.9MFY2017: 35.3MFY2018: 35.5MFY2019: 35.5MFY2020: 35.7MFY2021: 35.8MFY2022: 35.9MFY2023: 36.0MFY2024: 36.1MFY2025: 36.7M FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Automation Enabling Technologies 500.8M51.1% +2.1%
Medical Solutions 479.8M48.9% +4.6%

10-K 0001193125-26-064230, segment and revenue notes (XBRL).

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
United States 519.0M52.9% +6.5%
Rest of Europe 137.4M14.0% +6.6%
Germany 114.6M11.7% -7.0%
Rest of Asia-Pacific 97.0M9.9% -9.4%
China 93.2M9.5% +10.2%
Other Countries 19.3M2.0% +4.9%

10-K 0001193125-26-064230, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Automation Enabling Technologies-534.1M499.2M490.6M500.8M
Medical Solutions262.1M326.8M382.4M458.6M479.8M
Precision Medicine and Manufacturing232.5M274.7M283.0M--
Robotics and Automation212.3M308.2M273.5M--

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Medical Solutions17.7M28.2M41.9M--
Precision Medicine and Manufacturing46.8M63.8M69.3M--
Robotics and Automation52.7M60.3M48.4M--
Corporate and other-53.1M-49.2M-49.0M--

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Segments changed: FY2021, FY2022, FY2023 are in italics, as first reported under the earlier segments, so they are not comparable with the later years. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue384.8M521.3M614.3M626.1M590.6M706.8M860.9M881.7M949.2M980.6M
Cost of revenue222.3M300.8M352.8M364.0M346.1M406.5M482.4M481.8M527.7M545.3M
Gross profit162.5M220.5M261.5M262.1M244.5M300.3M378.5M399.9M421.5M435.3M
R&D32.0M41.7M51.0M56.0M61.0M72.5M85.8M91.7M95.5M95.5M
SG&A81.3M101.7M115.9M118.4M109.9M129.2M158.9M164.5M175.9M195.7M
Operating income33.0M57.6M71.0M55.3M55.9M64.1M103.1M110.5M110.6M94.0M
Interest expense2.9M5.8M8.9M8.4M5.5M6.2M14.3M25.3M32.7M22.6M
Pretax income32.5M76.1M61.3M45.8M48.4M56.2M87.2M83.7M79.1M69.6M
Income tax10.5M13.8M10.2M5.0M3.9M5.8M13.1M10.9M15.0M15.8M
Net income22.0M60.1M49.1M40.8M44.5M50.3M74.1M72.9M64.1M53.8M
EPS (diluted)0.631.131.431.151.251.412.062.021.771.47
Diluted shares34.9M35.3M35.5M35.5M35.7M35.8M35.9M36.0M36.1M36.7M
Depreciation & amortization21.0M30.8M37.1M38.3M38.3M43.4M53.2M46.6M55.6M61.9M
EBITDA53.9M88.3M108.1M93.6M94.2M107.4M156.2M157.1M166.1M155.9M
Gross margin42.2%42.3%42.6%41.9%41.4%42.5%44.0%45.4%44.4%44.4%
Operating margin8.6%11.0%11.6%8.8%9.5%9.1%12.0%12.5%11.6%9.6%
Net margin5.7%11.5%8.0%6.5%7.5%7.1%8.6%8.3%6.8%5.5%
Revenue growth+3.0%+35.5%+17.8%+1.9%-5.7%+19.7%+21.8%+2.4%+7.7%+3.3%
EPS growth-38.2%+79.4%+26.5%-19.6%+8.7%+12.8%+46.1%-1.9%-12.4%-16.9%

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow47.8M63.4M89.6M63.2M140.2M94.6M90.8M120.1M158.5M64.1M
Capital spending8.5M9.1M14.7M10.7M10.5M20.0M19.6M20.0M17.2M15.6M
Free cash flow39.3M54.3M75.0M52.5M129.7M74.6M71.1M100.1M141.3M48.4M
Stock-based pay (added back)4.3M5.5M7.7M9.3M23.1M25.6M23.1M25.6M23.3M29.5M
Free cash flow after stock pay35.0M48.8M67.3M43.2M106.6M49.0M48.0M74.5M118.0M18.9M
Buybacks1.6M370K5.8M10.0M5.5M-10.0M--39.3M
Acquisitions9.0M168.3M33.5M-------
Debt raised-176.8M55.3M66.8M-280.0M69.9M-198.0M82.8M
Debt repaid16.2M26.9M74.6M50.7M35.4M32.4M59.0M86.6M131.1M365.7M
Investing cash flow-12.9M-177.4M-45.6M-63.8M-13.2M-306.7M-42.5M-19.9M-208.2M-74.3M
Financing cash flow-23.2M143.3M-60.2M-3.9M-84.4M204.8M-60.2M-97.9M56.9M276.3M

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)4.3M5.5M7.7M9.3M23.1M25.6M23.1M25.6M23.3M29.5M
Stock-based pay / revenue1.1%1.1%1.3%1.5%3.9%3.6%2.7%2.9%2.5%3.0%
Operating lease cost-5.5M7.4M7.6M7.7M8.5M10.4M10.5M12.1M11.5M
Operating lease cash paid---7.8M6.8M7.8M7.9M7.8M11.2M12.0M
Finance lease principal paid---868K1.3M9.3M599K657K718K759K
Right-of-use assets---35.2M34.4M48.3M43.3M38.3M42.9M41.7M
Operating lease liabilities---39.2M39.0M53.0M48.6M45.5M50.4M48.7M
Finance lease liabilities---16.2M15.6M5.9M5.3M4.7M3.9M3.2M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NOVT/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.